Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LR20062 vs Hexaxim in healthy infants
NCT06618196Phase 2Not yet recruiting
- Sponsor
- LG Chem
- Start
- Oct 2024
- Primary completion
- Jun 2025
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of LR20062 in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by LG Chem. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
LR20062
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT06618196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06618196.